Recent research has shown that the elevated resistance of RCC to TKIs may be attributed to the overexpression of members of the VEGFA pathway, which serves as a compensatory mechanism in response to diminished KDR signaling upstream [10,11,26,50–52]. This evidence concerns the gene VEGFA and renal cell carcinoma.